Manager × security

BROADWOOD CAPITAL INC LCTX holdings history

Who else holds this security? →

LINEAGE CELL THERAPEUTICS IN · CUSIP 53566P109 · CIK 1278387

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, BROADWOOD CAPITAL INC reported 49.56M LCTX (shares), valued at $64.92M, or 3.39% of its reported non-derivative portfolio. Filed 2026-08-14.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
3.39%
Shares
49.56M
49,560,992
Reported value
$64.92M
USD

Shares unchanged; reported value decreased 17.09%, and weight changed -2.13 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20263.39%49,560,992SEC filing ↗Filed Aug 14, 2026
Q1 20265.52%49,560,992SEC filing ↗Filed May 15, 2026
Q4 20255.00%49,560,992SEC filing ↗Filed Feb 17, 2026
Q3 20255.07%49,560,992SEC filing ↗Filed Nov 14, 2025
Q2 20252.93%49,560,992SEC filing ↗Filed Aug 14, 2025
Q1 20251.81%49,560,992SEC filing ↗Filed May 15, 2025
Q4 20241.64%41,666,255SEC filing ↗Filed Feb 14, 2025
Q3 20242.89%41,666,255SEC filing ↗Filed Nov 14, 2024
Q2 20243.14%41,666,255SEC filing ↗Filed Aug 14, 2024
Q1 20244.63%41,666,255SEC filing ↗Filed May 15, 2024
Q4 20233.25%34,935,485SEC filing ↗Filed Feb 14, 2024

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 20233.25%34,935,485$38.08MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Feb 14, 2024
Q1 20244.63%41,666,255$61.67MShares increased 19.27%; reported value increased 61.94%, and weight changed +1.38 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2024
Q2 20243.14%41,666,255$41.55MShares unchanged; reported value decreased 32.61%, and weight changed -1.49 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2024
Q3 20242.89%41,666,255$37.72MShares unchanged; reported value decreased 9.22%, and weight changed -0.25 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2024
Q4 20241.64%41,666,255$20.94MShares unchanged; reported value decreased 44.49%, and weight changed -1.25 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2025
Q1 20251.81%49,560,992$22.38MShares increased 18.95%; reported value increased 6.90%, and weight changed +0.17 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2025
Q2 20252.93%49,560,992$44.97MShares unchanged; reported value increased 100.93%, and weight changed +1.12 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2025
Q3 20255.07%49,560,992$83.76MShares unchanged; reported value increased 86.25%, and weight changed +2.14 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2025
Q4 20255.00%49,560,992$82.77MShares unchanged; reported value decreased 1.18%, and weight changed -0.07 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 17, 2026
Q1 20265.52%49,560,992$78.31MShares unchanged; reported value decreased 5.39%, and weight changed +0.52 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2026
Q2 20263.39%49,560,992$64.92MShares unchanged; reported value decreased 17.09%, and weight changed -2.13 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2026
BROADWOOD CAPITAL INC · LINEAGE CELL THERAPEUTICS IN

Take these holdings further.

This page includes 11 of 11 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1278387","quarter":"2026Q2","cusip":"53566P109"}

get_institutional_manager_history
{"cik":"1278387","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.